Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2013 9
2014 4
2015 2
2016 2
2017 1
2019 1
2020 3
2021 2
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Distant antimetastatic effect of enterotropic colon cancer-derived α4β7+CD8+ T cells.
Feliu V, Gomez-Roca C, Michelas M, Thébault N, Lauzéral-Vizcaino F, Salvioni A, Scandella L, Sarot E, Valle C, Balança CC, Scarlata CM, Delord JP, Ayyoub M, Devaud C. Feliu V, et al. Among authors: devaud c. Sci Immunol. 2023 Jun 2;8(84):eadg8841. doi: 10.1126/sciimmunol.adg8841. Epub 2023 Jun 8. Sci Immunol. 2023. PMID: 37289857
CAR T-cell therapy of solid tumors.
Yong CSM, Dardalhon V, Devaud C, Taylor N, Darcy PK, Kershaw MH. Yong CSM, et al. Among authors: devaud c. Immunol Cell Biol. 2017 Apr;95(4):356-363. doi: 10.1038/icb.2016.128. Epub 2016 Dec 22. Immunol Cell Biol. 2017. PMID: 28003642 Review.
Colon-specific immune microenvironment regulates cancer progression versus rejection.
Trimaglio G, Tilkin-Mariamé AF, Feliu V, Lauzéral-Vizcaino F, Tosolini M, Valle C, Ayyoub M, Neyrolles O, Vergnolle N, Rombouts Y, Devaud C. Trimaglio G, et al. Among authors: devaud c. Oncoimmunology. 2020 Jul 12;9(1):1790125. doi: 10.1080/2162402X.2020.1790125. Oncoimmunology. 2020. PMID: 32923152 Free PMC article.
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells.
Balança CC, Salvioni A, Scarlata CM, Michelas M, Martinez-Gomez C, Gomez-Roca C, Sarradin V, Tosolini M, Valle C, Pont F, Ferron G, Gladieff L, Vergez S, Dupret-Bories A, Mery E, Rochaix P, Fournié JJ, Delord JP, Devaud C, Martinez A, Ayyoub M. Balança CC, et al. Among authors: devaud c. JCI Insight. 2021 Jan 25;6(2):e142513. doi: 10.1172/jci.insight.142513. JCI Insight. 2021. PMID: 33332284 Free PMC article.
Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade.
Martinez-Gomez C, Michelas M, Scarlata CM, Salvioni A, Gomez-Roca C, Sarradin V, Lauzéral-Vizcaino F, Féliu V, Dupret-Bories A, Ferron G, Sarini J, Devaud C, Delord JP, Balança CC, Martinez A, Ayyoub M. Martinez-Gomez C, et al. Among authors: devaud c. Cancers (Basel). 2022 Jul 28;14(15):3679. doi: 10.3390/cancers14153679. Cancers (Basel). 2022. PMID: 35954341 Free PMC article.
29 results